Literature DB >> 14700451

Long-term side effects of SSRIs: sexual dysfunction and weight gain.

Robert M A Hirschfeld1.   

Abstract

Selective serotonin reuptake inhibitors are associated with a variety of side effects, many of which are resolved during the first couple of weeks of treatment. Side effects that emerge or persist after 1 month of treatment include sexual dysfunction and weight gain. Although these adverse events are serious, they can be managed successfully if recognized early.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14700451

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  18 in total

Review 1.  Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Authors:  Branislav R Filipovic; Branka F Filipovic
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

2.  Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort study.

Authors:  Carmela Calandra; Rina Giuseppa Russo; Maria Luca
Journal:  Psychiatr Q       Date:  2012-06

3.  Bumetanide blocks the acquisition of conditioned fear in adult rats.

Authors:  Meng-Chang Ko; Ming-Chung Lee; Tso-Hao Tang; Tamara G Amstislavskaya; Maria A Tikhonova; Yi-Ling Yang; Kwok-Tung Lu
Journal:  Br J Pharmacol       Date:  2018-04-16       Impact factor: 8.739

4.  Desvenlafaxine and weight change in major depressive disorder.

Authors:  Karen A Tourian; Claire Leurent; Jay Graepel; Philip T Ninan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

5.  Study of effects of selective serotonin reuptake inhibitors on stages of sexual function in Iranian patients with major depressive disorder.

Authors:  Mitra Safa; Saeid Sadr; Firouzeh Talischi; Fatemeh Ghasem Boroujerdi
Journal:  Ther Adv Psychopharmacol       Date:  2013-12

Review 6.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

7.  S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Authors:  Anne Dekeyne; Clotilde Mannoury la Cour; Alain Gobert; Mauricette Brocco; Françoise Lejeune; Florence Serres; Trevor Sharp; Annie Daszuta; Amélie Soumier; Mariusz Papp; Jean-Michel Rivet; Gunnar Flik; Thomas I Cremers; Olivier Muller; Gilbert Lavielle; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-06-04       Impact factor: 4.530

8.  Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.

Authors:  Lee S Cohen; Hadine Joffe; Katherine A Guthrie; Kristine E Ensrud; Marlene Freeman; Janet S Carpenter; Lee A Learman; Katherine M Newton; Susan D Reed; Joann E Manson; Barbara Sternfeld; Bette Caan; Ellen W Freeman; Andrea Z LaCroix; Lesley F Tinker; Cathryn Booth-Laforce; Joseph C Larson; Garnet L Anderson
Journal:  Menopause       Date:  2014-04       Impact factor: 2.953

9.  Reproductive and other health outcomes in Iraq and Afghanistan women veterans using VA health care: association with mental health diagnoses.

Authors:  Beth E Cohen; Shira Maguen; Daniel Bertenthal; Ying Shi; Vanessa Jacoby; Karen H Seal
Journal:  Womens Health Issues       Date:  2012-09

10.  Preventing recurrent depression: long-term treatment for major depressive disorder.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.